Uncertainty of Liver Cirrhosis Diagnosis and Use of Elastography

Daniel M Aloise1, Guillermo Izquierdo2

  • 1Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, USA.

Cureus
|November 2, 2021
PubMed

Insights

Ultrasound elastography confirmed severe liver fibrosis in a patient with alcohol-induced liver cirrhosis. This non-invasive technique aids in diagnosing liver disease, offering therapeutic and prognostic benefits.

Area of Science:

  • Hepatology
  • Medical Imaging
  • Diagnostic Technology

Background:

  • Alcohol abuse is a leading cause of chronic liver disease.
  • Diagnosing liver cirrhosis often requires invasive methods like biopsy.
  • Elastography offers a non-invasive alternative for assessing liver fibrosis.

Observation:

  • A patient with a history of severe alcohol abuse presented with jaundice and elevated liver enzymes.
  • Clinical examination and laboratory tests suggested alcoholic liver disease and cirrhosis.
  • Ultrasound elastography was employed to non-invasively assess liver stiffness.

Findings:

  • Elastography revealed a mean shear wave velocity of 1.77 m/s.
  • This velocity correlated with a METAVIR score of F=4, indicating significant liver fibrosis.
  • The findings confirmed the diagnosis of alcohol-induced liver cirrhosis.

Implications:

  • Ultrasound elastography is a valuable, non-invasive tool for diagnosing liver cirrhosis.
  • This method can guide therapeutic decisions and improve patient prognosis.
  • Elastography reduces the need for liver biopsy in diagnosing liver fibrosis.

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
228
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
22
Ultrasonography01:17

Ultrasonography

Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
6.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
22